What is the price target for 4AB stock?
39 analysts have analysed 4AB.DE and the average price target is 217.08 EUR. This implies a price increase of 25.12% is expected in the next year compared to the current price of 173.5.
FRA:4AB • US00287Y1091
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABBVIE INC (4AB.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-08-02 | Mizuho | Maintains | Buy |
| 2021-08-02 | SVB Leerink | Maintains | Outperform |
| 2021-05-03 | BMO Capital | Maintains | Outperform |
| 2021-03-30 | SVB Leerink | Maintains | Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 54.318B -6.44% | 56.334B 3.71% | 61.16B 8.57% | 68.42B 11.87% | 73.977B 8.12% | 79.312B 7.21% | 83.389B 5.14% | 84.924B 1.84% | 86.73B 2.13% | 88.059B 1.53% | 88.73B 0.76% | |
| EBITDA YoY % growth | 25.251B -11.68% | 24.883B -1.46% | 29.077B 16.85% | 34.36B 18.17% | 37.952B 10.45% | 41.077B 8.23% | 40.135B -2.29% | 39.315B -2.04% | 38.815B -1.27% | 39.343B 1.36% | N/A | |
| EBIT YoY % growth | 16.553B -17.74% | 16.497B -0.34% | 20.938B 26.92% | 32.948B 57.36% | 36.62B 11.14% | 39.37B 7.51% | 43.079B 9.42% | 44.038B 2.23% | 45.267B 2.79% | 46.821B 3.43% | 47.339B 1.11% | |
| Operating Margin | 30.47% | 29.28% | 34.23% | 48.16% | 49.50% | 49.64% | 51.66% | 51.86% | 52.19% | 53.17% | 53.35% | |
| EPS YoY % growth | 11.11 -19.90% | 10.12 -8.91% | 10.00 -1.19% | 14.83 48.29% | 16.41 10.66% | 18.16 10.68% | 19.64 8.13% | 20.18 2.76% | 20.68 2.45% | 21.19 2.48% | 20.87 -1.52% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.80 13.66% | 3.86 29.91% | 3.93 111.04% | 4.02 48.46% | 3.32 18.67% | 4.21 9.03% | 4.26 8.54% | 4.40 9.35% |
| Revenue Q2Q % growth | 15.012B 12.51% | 17.146B 11.17% | 17.741B 12.46% | 18.509B 11.38% | 16.148B 7.57% | 18.194B 6.11% | 18.909B 6.58% | 19.443B 5.05% |
| EBITDA Q2Q % growth | 6.397B 6.26% | 8.897B -9.27% | 9.031B -22.03% | 8.926B -36.01% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 6.415B 61.14% | 8.556B 49.66% | 8.711B 60.39% | 8.692B 49.63% | 7.571B 18.02% | 8.798B 2.83% | 9.322B 7.01% | 9.599B 10.43% |
All data in USD
39 analysts have analysed 4AB.DE and the average price target is 217.08 EUR. This implies a price increase of 25.12% is expected in the next year compared to the current price of 173.5.
ABBVIE INC (4AB.DE) will report earnings on 2026-04-29, before the market open.
The consensus EPS estimate for the next earnings of ABBVIE INC (4AB.DE) is 2.8 EUR and the consensus revenue estimate is 15.01B EUR.
The number of analysts covering ABBVIE INC (4AB.DE) is 39.